Patents Examined by Amy L. Clark
  • Patent number: 11026915
    Abstract: The present invention comprises a method of manufacturing a cannabinoid solution including adding to a cannabis source comprising a cannabis distillate or a full spectrum alcohol extracted cannabis oil, adding a PEG, forming a mixture; and adding a PG to the mixture, forming the cannabinoid solution suitable for vaporization and inhalation to administer active cannabis compounds to a person in need thereof.
    Type: Grant
    Filed: February 1, 2018
    Date of Patent: June 8, 2021
    Assignee: 1091665 B.C. Ltd.
    Inventors: Deryl Townsend, Haydn Wilford, Ian Hillier-Brook
  • Patent number: 11020486
    Abstract: Injectable formulations comprising ethanol, sesame oil, and an Immune Response Modifier compound are disclosed. Methods of making the formulations and methods of using the formulations for treatment of a disease in a subject, e.g., neoplastic disease, comprising injecting the formulations into a subject hi need of treatment, are also provided.
    Type: Grant
    Filed: October 30, 2014
    Date of Patent: June 1, 2021
    Inventors: Joseph M. Beaurline, James M. Elvecrog, John P. Vasilakos, John Thomas Capecchi, Karen Elizabeth Johnson
  • Patent number: 11000569
    Abstract: A medicament for use in treating fatty liver, hepatitis and cirrhosis, the medicament includes a marine algal glycoprotein.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: May 11, 2021
    Inventors: Qian Cheng, Baozhen Xu, Long Cheng
  • Patent number: 10987390
    Abstract: Embodiments of the invention include plant stem cell products and treatment methods using the products. In some embodiments, the products may include extracts of plant stem cells, such as apple stem cells, and an aerosolizing device configured to create an aerosol from the plant stem cell products and to deliver the aerosol to the lung via inhalation. Treatment methods include aerosol inhalation of the plant stem cell products.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: April 27, 2021
    Inventors: Maryam Rahimi, Steven Phillip Gallagher
  • Patent number: 10980843
    Abstract: Bee venom nanoparticles and methods of synthesizing bee venom nanoparticles are provided. The bee venom nanoparticles may be synthesized by drying bee venom, suspending the dried bee venom in a solvent to form a first bee venom solution, spraying the first bee venom solution into boiling water under ultrasonic conditions to form a bee venom solution including the bee venom nanoparticles, stirring the bee venom solution including the bee venom nanoparticles, and freeze-drying the bee venom solution. The resulting nanoparticles may be used in pharmaceutical compositions, and may be useful for their antimicrobial activities.
    Type: Grant
    Filed: February 25, 2020
    Date of Patent: April 20, 2021
    Inventors: Reem Atta Alajmi, Nadin Mohamed Moubayed, Manal Ahmed Gasmelseed Awad, Hany Mohamed Yehia, Manal Fawzy Elkhadragy, Ibrahim Abdullah Barakat, Faten Nasser Alsaqabi, Amany Zein Elabedein Mahmoud Elshahidy
  • Patent number: 10973865
    Abstract: Provided are methods of making an extract of fruit of the Solanaceae family wherein fruit is processed to optimise the platelet aggregation inhibiting activity of the extract. The methods involve preparing a start mix of homogenised fruit; separating a water soluble fraction from fruit solids; filtration of the water soluble fraction; and concentration of active agents in the filtration permeate. The invention also provides fruit extracts manufactured by such methods, and also fruit extracts containing glycosylated phenolic acid or a phenolic ester, or derivatives thereof, a glycosylated flavonoid; and a nucleoside. The extracts of the invention are useful as medicaments for the treatment or prevention of a medical condition characterised by inappropriate platelet aggregation. In particular, the medicaments may be of use in maintaining heart health by reducing platelet aggregation; benefiting the circulation, and/or normalizing or otherwise benefiting blood flow.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: April 13, 2021
    Assignee: Provexis Natural Products Limited
    Inventor: Niamh O'Kennedy
  • Patent number: 10973851
    Abstract: Herbo-mineral formulation for prevention and treatment of Renal disorders are disclosed herein. The formulation includes combination of herb and mineral elements for treating Renal disorders. Renal disorders include any condition associated with Kidney function such as Chronic renal failure.
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: April 13, 2021
    Assignee: Muniyal Ayurvedic Research Centre
    Inventor: M Vijayabhanu Shetty
  • Patent number: 10960016
    Abstract: Oral capsules have been dismissed as a dosage form for delivery high dosages of krill phospholipids, but by purifying these to high levels it is indeed possible to use this dosage form to deliver, for example, 700 mg or more phospholipids per capsule.
    Type: Grant
    Filed: February 12, 2015
    Date of Patent: March 30, 2021
    Assignee: Aker BioMarine Antarctic AS
    Inventors: Stefan Hupfeld, Tove Jule Evjen, Finn Myhren, Håvard Thøgersen
  • Patent number: 10961326
    Abstract: The present disclosure relates, according to some embodiments, to methods and systems for purifying proteins, carbohydrate rich products, and polysaccharide products from a microcrop (e.g., photosynthetic aquatic species) and compositions thereof. For example, the present disclosure relates, in some embodiments to methods and systems for extracting proteins, dry biocrude, carbohydrate-rich meal, and polysaccharide products from Lemna.
    Type: Grant
    Filed: July 6, 2016
    Date of Patent: March 30, 2021
    Assignee: Parabel Nutrition, Inc.
    Inventors: Peter Sherlock, Ruben Garcia Gonzalez
  • Patent number: 10953067
    Abstract: An herbal composition, comprising a therapeutically effective amount of an extract of Terminalia chebula; a therapeutically effective amount of an extract of Curcuma longa; and a therapeutically effective amount of a non-acidic, water-immiscible organic solvent extract of a Boswellia serrata resin.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: March 23, 2021
    Inventors: Ganga Raju Gokaraju, Rama Raju Gokaraju, Venkata Kanaka Ranga Raju Gokaraju, Trimurtulu Golakati, Kiran Bhupathiraju, Venkata Krishna Raju Alluri, Krishanu Sengupta
  • Patent number: 10947497
    Abstract: The present invention relates to Nelumbo nucifera callus having an increased content of gallic acid or an extract thereof and to a method for preparing the same. The Nelumbo nucifera callus extract according to the present invention has an excellent whitening effect by containing a large amount of gallic acid, and thus can be advantageously used as a cosmetic composition.
    Type: Grant
    Filed: March 30, 2017
    Date of Patent: March 16, 2021
    Assignees: Celltrion Inc., BIO-FD&C Co., Ltd.
    Inventors: Yeon Sook Kim, Jung Yeon Kim, Jae Hun Kim, Hyeong Mi Kim, Jung Soo Bae, Jung Yun Kim, Ju Yeon Kim, Joo Hyuck Lim, Seung Ki Lee, Sung Ho Moon, Shin Jae Chang, Sang Hyun Moh, Jeong Hun Lee, Hyo Hyun Seo, Ji Hong Moh, Soo Yun Kim, Jeong Gon Park
  • Patent number: 10946058
    Abstract: Described herein are food additives prepared from the inner core of a banana plant stem, along with methods of making and using same.
    Type: Grant
    Filed: March 26, 2014
    Date of Patent: March 16, 2021
    Inventor: Uppala Rajakaruna
  • Patent number: 10940175
    Abstract: The invention relates to Boswellia frereana and particularly an extract of same for treating a range of inflammatory disorder or conditions selected from the group comprising: inflammatory bowel disease (IBD), all forms of muscular dystrophy especially Duchenne muscular dystrophy, sepsis, sepsis syndrome, osteoporosis, ischemic injury, graft vs. host disease, reperfusion injury, asthma, diabetes, cancer, myelogenous and other leukemias, psoriasis and cachexia, Alzheimer's Disease, demyelinating neurological disorders including multiple sclerosis, acetylcholinesterase mediated disorders, retinal disorders, neurological, retinal, and muscular disorders.
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: March 9, 2021
    Inventors: Emma Jane Blain, Victor Collin Duance, Ahmed Yasine Ali, Ifor Delme Bowen
  • Patent number: 10925910
    Abstract: A novel treatment for topical inflammatory conditions such as acne, eczema, shingles, insect bites, and hives is provided, consisting of the application of a herbal cream or ointment which incorporates grounded PawPaw Seeds in a granular form. The cream preferably contains one or more thickeners, a bio-adhesive agent such as petroleum jelly such that the cream can stick to the area to be treated.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: February 23, 2021
    Inventor: Emmanuel Osei-Kumi
  • Patent number: 10905800
    Abstract: An ocular covering fabricated from at least one amniotic membrane, at least one chorionic membrane, or at least one amniotic membrane and at least one chorionic membrane obtained from human birth tissue is provided. Methods of preparing the one or more membranes to form an ocular covering are provided. Methods of treating a disease, condition, or surgical site of the eye and surrounding tissue are also provided.
    Type: Grant
    Filed: January 29, 2014
    Date of Patent: February 2, 2021
    Assignee: BioDlogics, LLC
    Inventor: Timothy R. Brahm
  • Patent number: 10905139
    Abstract: Disclosed is a beverage and a method of administering the beverage. The beverage is free of phosphoric acid and instead contains at least 0.3% by weight/volume of gluconic acid, is low in minerals, specifically contains less than 250 mg/liter of minerals, is low in sugar, specifically contains at most 2.5% by weight/volume of sugar. These sugars comprise at least 10% weight/weight galactose and in addition a proportion of isomaltulose and/or tagatose The beverage has a glycemic index of at most 35 (GI<35).
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: February 2, 2021
    Inventor: Johannes Coy
  • Patent number: 10898611
    Abstract: A bone implant comprising cancellous bone that is essentially free of blood cells, and which has been treated with at least one loosening agent, such as collagenase or a digestive enzyme, for a time and at a concentration to loosen the osteogenic cells in the cancellous bone matrix. The osteogenic cells in the matrix are viable cells. The treatment of the cancellous bone with at least one loosening agent enables the osteogenic cells to be more available for carrying out their osteogenic function and to provide for an increased rate of bone formation. Such implant also may include demineralized bone, such as demineralized cortical bone, which enhances the bone regenerative capacity of the cancellous bone.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: January 26, 2021
    Assignee: NuVasive, Inc.
    Inventors: Michelle LeRoux Williams, Charles Randal Mills, Rodney Monroy, Robert A. Zambon, Dayna Buskirk, Earl Fender
  • Patent number: 10894070
    Abstract: A pharmaceutical composition includes an alcohol-soluble, water insoluble, extract of Radix Glycyrrhizae; and wolfberry. A weight ration of the extract and wolfberry is 0.01˜5:15˜25. The composition is useful for controlling blood glucose and blood lipids, and for weight control. Health food products containing the recited combination are also provided.
    Type: Grant
    Filed: March 26, 2012
    Date of Patent: January 19, 2021
    Inventors: James Zhou, Dong Chen
  • Patent number: 10894072
    Abstract: Embodiments of the invention generally relate to supplements for treating fibromyalgia and symptoms associated with fibromyalgia, wherein the nutritional supplement is administered for at least one of following: fatigue, chronic pain, morning stiffness, headaches, and problems with thinking and memory.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: January 19, 2021
    Assignee: IP Quality Holdings, LLC
    Inventors: Amy L. Heaton, Dennis Gay
  • Patent number: 10881104
    Abstract: The present invention generally relates to compositions and methods related to controlling arthropods. Embodiments of the invention include compositions for controlling an arthropod, which can include one or more plant essential oils and methods for using these compositions. The plant essential oils, when combined, can have a synergistic effect. Embodiments of the invention relate to compositions and methods related to controlling lice.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: January 5, 2021
    Assignee: TYRATECH, INC.
    Inventors: Keith Kennedy, Jason Schmidt